Reason for withdrawal from publication
The most up‐to‐date results from the EBCTCG overview are available from the Clinical Trial Service Unit and Epidemiological Studies Unit website (http://www.ctsu.ox.ac.uk/projects/ebctcg/) and reprints of the EBCTCG papers can be requested by emailing bc.overview@ctsu.ox.ac.uk
The Early Breast Cancer Trialists Collaborative Group (EBCTCG) conducts periodically updated individual patient data meta‐analyses of randomised trials pertaining to the effects of local and systemic therapy on recurrence, second cancers and mortality. These systematic reviews are of the highest quality, are updated every five years and are published in prominent peer‐reviewed journals. They represent the best available evidence on the effects of these treatments on relapse, second cancer and death.
Converting each of the EBCTCG reviews into a Cochrane format as they are updated represents unnecessary duplication of effort and this Cochrane review, which was based on earlier cycles of data collection and analysis by the EBCTCG, has now been withdrawn.
The editorial group responsible for this previously published document have withdrawn it from publication.
What's new
| Date | Event | Description |
|---|---|---|
| 6 August 2008 | Amended | Converted to new review format. |
History
Protocol first published: Issue 1, 1998 Review first published: Issue 1, 2001
| Date | Event | Description |
|---|---|---|
| 6 August 2001 | New citation required and conclusions have changed | Substantive amendment |
Sources of support
Internal sources
No sources of support supplied
External sources
Cancer Research UK (formerly Imperial Cancer Research Fund UK), UK.
Withdrawn from publication for reasons stated in the review